1.Identification of a new pyruvate kinase M2 isoform (PKM2) activator for the treatment of non-small-cell lung cancer (NSCLC)

Li, RZ, Fan, XX, Shi     More...

Li, RZ, Fan, XX, Shi, DF, Zhu, GY, Wang, YW, Luo, LX, Pan, HD, Yao, XJ, Leung, ELH, Liu, L     Less

CHEMICAL BIOLOGY & DRUG DESIGN[1747-0277], Published 2018, Volume 92, Issue 5, Pages 1851-1858

收錄情况： WOS SCOPUS

WOS核心合集引用: 23  2024影響因子:  3.3  发表年影響因子:  2.256 

2.Pyronaridine induces apoptosis in non-small cell lung cancer cells by upregulating death receptor 5 expression and inhibiting epidermal growth factor receptor

Zhong, ZH, Yi, ZL, Z     More...

Zhong, ZH, Yi, ZL, Zhao, YD, Wang, J, Jiang, ZB, Xu, C, Xie, YJ, He, QD, Tong, ZY, Yao, XJ, Leung, ELH, Coghi, PS, Fan, XX, Chen, M     Less

CHEMICAL BIOLOGY & DRUG DESIGN[1747-0277], Published 2022, Volume 99, Issue 1, Pages 83-91

收錄情况： WOS SCOPUS

WOS核心合集引用: 10  2024影響因子:  3.3  发表年影響因子:  3.0 

3.ZYZ384 suppresses the growth of EGFR-mutant non-small cell lung cancer by activating JNK/MAPK signaling pathway

Nie, XW, Nasim, AA,     More...

Nie, XW, Nasim, AA, Yao, XJ, Fan, XX     Less

CHEMICAL BIOLOGY & DRUG DESIGN[1747-0277], Published 2023, Volume 103, Issue 1,

收錄情况： WOS SCOPUS

WOS核心合集引用: 2  2024影響因子:  3.3  发表年影響因子:  3.2